Trial intelligence / Profile preview

LMX 4 for Cutaneous Abscess in Children

NCT05461053Phase 4Withdrawn

Sponsor
Rush University Medical Center
Start
Jan 2025
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine in cutaneous abscess, sponsored by Rush University Medical Center. Planned start Jan 2025; status: withdrawn.

02

Drugs

lidocaine
03

Conditions

cutaneous abscess

Beyond the preview

Go deeper on NCT05461053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05461053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call